{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:06:31Z","timestamp":1773983191649,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:00:00Z","timestamp":1703376000000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.niox.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:23:30Z","timestamp":1671589410000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Heterogenous improvements in endothelial function by sub-blood pressure lowering doses of ARBs result in major anti-aortic root remodeling effects"],"prefix":"10.1016","volume":"131","author":[{"given":"Arash Y.","family":"Tehrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Donen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: an endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1074\/jbc.M113.528190","article-title":"Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C \u03b5-mediated zona occludens-1 phosphorylation at threonine 770\/772","volume":"289","author":"Chattopadhyay","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2022.12.002_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcvm.2018.00151","article-title":"J. Endothelial\u2013vascular smooth muscle cells interactions in atherosclerosis","volume":"5","author":"Li","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.niox.2022.12.002_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2016.03.007","article-title":"Vascular endothelium - gatekeeper of vessel health","volume":"248","author":"Cahill","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.niox.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2022.12.002_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1533317516653820","article-title":"Vascular function in alzheimer's disease and vascular dementia","volume":"31","author":"Tachibana","year":"2016","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"key":"10.1016\/j.niox.2022.12.002_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184329","article-title":"Molecular characteristics and treatment of endothelial dysfunction in patients with COPD: a review article","volume":"20","author":"Szucs","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.104.509760","article-title":"Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179","volume":"112","author":"Watanabe","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2125.2012.04189.x","article-title":"Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants","volume":"74","author":"Mason","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.niox.2022.12.002_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096948","article-title":"Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells","volume":"9","author":"Myojo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2022.12.002_bib11","article-title":"Blood pressure\u2010independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan","volume":"9","author":"Tehrani","year":"2021","journal-title":"Phys. Rep."},{"key":"10.1016\/j.niox.2022.12.002_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","article-title":"Inhibition of marfan syndrome aortic root dilation by losartan: role of angiotensin II receptor type 1-independent activation of endothelial function","volume":"188","author":"Sellers","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"1 12","key":"10.1016\/j.niox.2022.12.002_bib13","first-page":"1","article-title":"Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects","volume":"12","author":"Tehrani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.niox.2022.12.002_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.niox.2022.12.002_bib15","article-title":"Aortic and cardiac structure and function using high-resolution echocardiography and optical coherence tomography in a mouse model of marfan syndrome","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsb.2014.07.003","article-title":"Quantification of aortic and cutaneous elastin and collagen morphology in Marfan syndrome by multiphoton microscopy","volume":"187","author":"Cui","year":"2014","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.niox.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2125.2012.04189.x","article-title":"Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants","volume":"74","author":"Mason","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.niox.2022.12.002_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096948","article-title":"Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells","volume":"9","author":"Myojo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2022.12.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107112","article-title":"Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties","volume":"147","author":"Sauge","year":"2022","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.niox.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"13277","DOI":"10.1021\/bi961720e","article-title":"Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization","volume":"35","author":"Liu","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.niox.2022.12.002_bib21","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M106302200","article-title":"Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme","volume":"277","author":"Fulton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2022.12.002_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.niox.2022.12.002_bib23","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1073\/pnas.1922608117","article-title":"\u03b2-Arrestin2 is a critical component of the GPCR-eNOS signalosome","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2022.12.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109967","article-title":"Adrenal angiotensin II type 1 receptor biased signaling: the case for \u2018biased\u2019 inverse agonism for effective aldosterone suppression","volume":"82","author":"Ferraino","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.niox.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal \u03b2arrestin1-dependent aldosterone production by ARBs: head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.niox.2022.12.002_bib26","article-title":"The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases","volume":"38 33","author":"Abraham","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.niox.2022.12.002_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.niox.2022.12.002_bib28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1476-5381.2009.00443.x","article-title":"Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome","volume":"158","author":"Yang","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2022.12.002_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2016.04.186","article-title":"The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials","volume":"217","author":"Gao","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.niox.2022.12.002_bib33","article-title":"Role of losartan in prevention of aortic dilatation in Marfan syndrome: a systematic review and meta-analysis","volume":"204748731986123","author":"Li","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.niox.2022.12.002_bib34","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(19)32518-8","article-title":"Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial","volume":"394","author":"Mullen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2022.12.002_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.niox.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2022.12.002_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.99.7.909","article-title":"Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation","volume":"99","author":"Wilson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.niox.2021.08.006","article-title":"Nitric oxide in the Marfan vasculature: friend or foe?","volume":"116","author":"Tehrani","year":"2021","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2022.12.002_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.4266","article-title":"Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome","volume":"23","author":"Oller","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2022.12.002_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006438","article-title":"Cardiovascular benefits of moderate exercise training in marfan syndrome: insights from an animal model","volume":"6","author":"Mas-Stachurska","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.niox.2022.12.002_bib42","doi-asserted-by":"crossref","DOI":"10.1152\/japplphysiol.00132.2017","article-title":"Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm","volume":"123","author":"Gibson","year":"2017","journal-title":"J. Appl. Physiol."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:08:50Z","timestamp":1761070130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860322001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S1089860322001355"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2022.12.002","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogenous improvements in endothelial function by sub-blood pressure lowering doses of ARBs result in major anti-aortic root remodeling effects","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}